Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for IceCure Medical (ICCM) over the last 5 years, with Q1 2025 value amounting to -$213000.0.

  • IceCure Medical's Change in Accured Expenses fell 43281.25% to -$213000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $561000.0, marking a year-over-year increase of 18050.0%. This contributed to the annual value of $838000.0 for FY2024, which is 37119.74% up from last year.
  • Latest data reveals that IceCure Medical reported Change in Accured Expenses of -$213000.0 as of Q1 2025, which was down 43281.25% from $501000.0 recorded in Q4 2024.
  • In the past 5 years, IceCure Medical's Change in Accured Expenses ranged from a high of $1.1 million in Q1 2022 and a low of -$852000.0 during Q2 2022
  • For the 5-year period, IceCure Medical's Change in Accured Expenses averaged around $88666.7, with its median value being $24500.0 (2022).
  • As far as peak fluctuations go, IceCure Medical's Change in Accured Expenses soared by 170666.67% in 2023, and later tumbled by 43281.25% in 2025.
  • Quarter analysis of 5 years shows IceCure Medical's Change in Accured Expenses stood at -$252000.0 in 2021, then soared by 94.05% to -$15000.0 in 2022, then skyrocketed by 1706.67% to $241000.0 in 2023, then surged by 107.88% to $501000.0 in 2024, then plummeted by 142.51% to -$213000.0 in 2025.
  • Its Change in Accured Expenses was -$213000.0 in Q1 2025, compared to $501000.0 in Q4 2024 and -$51000.0 in Q3 2024.